Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Dec 29,2017
Hidden Structural Variations Emerge from Long Reads of a Complex Genome
Genomes assembled from shreds and patches may fail to represent all mutations, which include not only the single-nucleotide variants and small indels so ably detected by standard short-read sequencing methods, but also mutations that add, subtract, rearrange, or otherwise reconfigure genomic structures. Genomes more resplendent may be needed – genomes that are assembled from longRead more
More
Dec 28,2017
Team Takes Important Step in Better Understanding Calcific Aortic Valve Disease
The diminutive size of our aortic valve – just shy of a quarter – belies its essential role in pushing oxygen-rich blood from the heart into the aorta, our body's largest vessel, and from there to all other organs. Yet for decades, researchers have focused less on damaged valves than on atherosclerosis, the gradual hardeningRead more
More
Dec 28,2017
Five New Genomic Regions Found that Boost Risk of Asthma
Asthma is a chronic inflammatory disesase involving the airway in the lungs that affects more than 300 million people worldwide including 10 to 20 % of children. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. It has a significant socio-economic impact and characterized by clinical heterogeneity. Asthma results from genetic predisposition and exposure toRead more
More
Dec 27,2017
Team Shows How Dicer Protein Detects and Destroys Viral Invaders
When viruses infect the body’s cells, those cells face a difficult problem. How can they destroy viruses without harming themselves?  Researchers at University of Utah Health have discovered a protein that cuts apart the genetic material of harmful invading viruses. Their research shows how the protein detects the intruders and processes them for destruction to protect cellsRead more
More
Dec 27,2017
Technique Converts Harmful Autoantibodies into Anti-Inflammatory Antibodies In Vivo
A team of Massachusetts General Hospital (MGH) and Harvard Medical School investigators have found a way to engineer antibodies within an organism, converting autoantibodies that attack "self” tissues into anti-inflammatory antibodies in animal models of two autoimmune diseases. The technology, developed in the laboratory of Robert Anthony, Ph.D., at the Center for Immunology and InflammatoryRead more
More
Technique Converts Harmful Autoantibodies into Anti-Inflammatory Antibodies In Vivo
Dec 26,2017
Nanomedicine Technique Advances Effectiveness of Cancer Therapy
Oregon State University (OSU) scientists have developed a nanomedicine platform for cancers that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed. The scientists from the OSU/Oregon Health & Science University (OHSU) College of Pharmacy and OSU College of Veterinary Medicine published their study ("A Tumor-ActivatableRead more
More
Nanomedicine Technique Advances Effectiveness of Cancer Therapy
Dec 26,2017
Moving a Step Closer to Solving Problems of Autoimmune Disease and Transplant Rejection
Researchers at the Houston Methodist Research Institute report that they have identified a critical switch that controls T-cell function and dysfunction and have discovered a pathway to target it. Their study ("Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction”) appears in Immunity.   According to Wenhao Chen, Ph.D., a scientistRead more
More
Moving a Step Closer to Solving Problems of Autoimmune Disease and Transplant Rejection
Dec 26,2017
What is PCR (Polymerase Chain Reaction)?
PCR (Polymerase Chain Reaction) technology is a DNA synthesis amplification technology in vitro. It has the characteristics of high amplification efficiency, high amplification specificity, and simple and mature amplification system and technology. It is the most widely used technology in biology-related laboratories today.
More
What is PCR (Polymerase Chain Reaction)?
Dec 22,2017
Arthritis Drug Combined with Anticancer Therapeutic Shows Promise against Melanoma
Researchers say that treatment for the most deadly form of skin cancer could be more effective if combined with a well-known drug for rheumatoid arthritis. Scientists from the University of East Anglia (UEA) in Norwich, England, working with mice, discovered found that the two treatments together almost completely stopped the growth of a melanoma tumor.  Read more
More
Dec 22,2017
Knockout Gene Model Has a Nose for Knockout Breath
Halitosis, or chronic bad breath, afflicts both mice and men, and mice may be used to model human halitosis. But scientists don't have to put their noses up to mice's mouths. Just ask the scientists who participated in an international effort to study halitosis at the genetic level. By studying patients from families afflicted withRead more
More
Knockout Gene Model Has a Nose for Knockout Breath
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->